Introduction:
Keratoconus, a progressive eye disorder causing thinning and bulging of the cornea, has long posed a challenge for both patients and ophthalmologists. Until recently, treatment options were limited, and doctors often performed corneal transplants for severe cases.
New treatment for Keratoconus:
Keratoconus affects the structure of the cornea, the transparent outer layer of the eye. TREATMENT FOR KERATOCONUS Normally, the cornea has a round shape, but in individuals with keratoconus, it progressively thins and begins to bulge into a cone-like shape.
Traditional Treatment Challenges for keratoconus treatment:
While effective in some cases, these solutions only address symptoms and fail to halt the progression of the condition. In advanced stages, when vision becomes severely impaired, corneal transplants were often the last resort.
Corneal Cross-Linking for keratoconus treatment:
During a CXL procedure, doctors apply riboflavin (vitamin B2) eye drops to the cornea and then expose it to ultraviolet (UV) light. This combination induces a chemical reaction that strengthens the collagen fibers within the cornea, enhancing its stability and halting the progression of keratoconus
.Benefits of Corneal cross linking for keratoconus:
- Halts Disease Progression: By fortifying the cornea, CXL effectively halts the progression of keratoconus, preserving vision and reducing the need for more invasive treatments.
- Minimally Invasive: Compared to corneal transplants, CXL is a minimally invasive outpatient procedure that can be performed in a clinic setting.
- Short Recovery Time: Most patients experience minimal discomfort and a quick recovery period following CXL, allowing them to resume normal activities shortly after the procedure.
- Long-Term Results: Studies have shown that the benefits of CXL are long-lasting, providing sustained improvement in vision and stability of the cornea over time.
Author Details:
Dr. Sushruth Appajigowda holds a prominent position as a Cornea, Cataract, Glaucoma, and LASIK Surgeon in Bangalore. He serves as the chief Cataract and Refractive surgeon at Vijaya Nethralaya Eye Hospital, Nagarbhavi Bangalore. Renowned as one of the finest LASIK surgeons nationwide, he brings with him over 12+ years of experience across multiple LASIK platforms, including ZEISS, ALCON, SCHWIND, AMO, and Bausch and Lomb. Having successfully conducted over 5000 LASIK procedures, Dr. Sushruth holds the title of a Certified Refractive Surgeon and a Fellow of the All India Collegium Of Ophthalmology. Furthermore, he stands as a distinguished speaker at various National and International Forums, using his expertise to guide you in selecting the most suitable procedure based on your health requirements.
http://vijayanethralaya.com/link-in-bio/
Conclusion:
The advent of corneal cross-linking represents a beacon of hope in their journey toward clearer vision and improved quality of life. As awareness of this groundbreaking treatment grows, so too does the potential to transform the lives of countless individuals affected by this sight-threatening condition.
